Page 29 - Journal of Structural Heart Disease Volume 4, Issue 3
P. 29
Meeting Abstracts
86
1. Figure 2. Balloon Dilatation during PTMC.
MVA increased from 0.6 to 1.3 cm2 as shown in Fig 2, MV gradient decreased from 17mmHg to 7mmHg, mean left atrial pressure decreased from 15 to 7 mmHg. There was no increase in MR. During the procedure patient went into vasovagal reaction. Patient discharged after therapeutic range of INR was achieved. Patients is currently under fol- low with NYHA I symptom.
1. Figure 3. MVA=0.7cm2 before PTMC.
Conclusion: In patients with suitable valve morphology, PTMC can be done successfully in MS following MV repair for severe MS. This may help to delay the need for MVR in younger patients.
1. Figure 4. MVA=1.3cm2 post PTMC.
References:
1. Kumar AS, Talwar S, Saxena A, Singh R, Velayoudam D. Results
of mitral valve repair in rheumatic mitral regurgitation. Inter- act Cardiovasc Thorac Surg. 2006;5:356–361.
2. Choudhary SK, Talwar S, Dubey B, Chopra A, Saxena A, Kumar AS. Mital valve repair in a predominantly rheumatic popula- tion. Long-term results. Tex Heart Inst J. 2001;28:8–15.
3. Iung B, Vahanian A. Rheumatic mitral valve disease. In: Otto CM, Bonow RO, eds. In: Valvular Heart Disease: A Companion to Braunwald's Heart Disease 4th ed. Philadelphia: Saunders; 2013:255–277.
4. Lachikarathman Devegowda, Prabhavathi Bhat, Cholenahal- ly Nanjappa Manjunath C, Prasanna Simha Mohan Rao. Case Report PTMC in post-MV repair status. Indian Heart Journal
2016;68:s8-s10.
2. EXPERIENCE ON TRANSCATHETER CLOSURE OF PATENT DUCTUS ARTERIOSUS IN NEPAL
Chandra Mani Adhikari1, Urmila Shakya2, Manish Shrestha2,1, Poonam Sharma2,1, Shilpa Aryal2, Achhita KC1, Rabi Malla1
1 Department of Cardiology, Shahid Gangalal National Heart Centre, Kathmandu, Nepal
2 Department of Paediatric Cardiology, Shahid Gangalal National Heart Centre, Kathmandu, Nepal
Background and Aims: In the current era, transcatheter clo- sure of patent ductus arteriosus (PDA) using either coils or device is a well-established procedure.We want to describe our experience in PDA device closure in Nepal.
Methods: It was a retrospective study done with the hospi- tal catheterization laboratory records. Patients age, gender device used any adverse outcome were analyzed.
Journal of Structural Heart Disease, April 2018
Volume 4, Issue 2:85-113